Aptose Clinical Data Featured in Poster Presentation at the 2024 ASH Annual Meeting Support ...
TUS+VEN+AZA Triplet Frontline Therapy in Newly Diagnosed AML Patients Now Enrolling at U.S. SitesTUS and TUS+VEN Broadly Active Across AML ...